News · Antisense Oligonucleotide (ASO)
83 stories
Sep 9, 26Novo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander disease
Sep 4, 26STAT+: After failure of Angelman syndrome drug, experts see hope in other experimental therapies
Sep 4, 26Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
Aug 31, 26ESC: Alnylam's next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CM